FDG-PET for management of cervical and ovarian cancer
Top Cited Papers
- 1 April 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (1) , 183-191
- https://doi.org/10.1016/j.ygyno.2004.12.007
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Usefulness of FDG PET for Assessment of Early Recurrent Epithelial Ovarian CancerAmerican Journal of Roentgenology, 2002
- 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose Positron Emission Tomography in the Diagnosis of Recurrent Ovarian CancerGynecologic Oncology, 2001
- Positive Emission Tomography for Evaluating a Complete Clinical Response in Patients with Ovarian or Peritoneal Carcinoma: Correlation with Second-Look LaparotomyGynecologic Oncology, 2001
- Clinical Impact of 18F-FDG-PET in the Suspicion of Recurrent Ovarian Carcinoma Based on Elevated Tumor Marker Serum LevelsClinical Positron Imaging, 2000
- Diagnosis of Recurrent Uterine Cervical Cancer: Computed Tomography versus Positron Emission TomographyKorean Journal of Radiology, 2000
- Cervical carcinoma: Computed tomography and magnetic resonance imaging for preoperative stagingObstetrics & Gynecology, 1995
- Whole-Body Positron Emission Tomography with 2-[18F]-Fluoro-2-deoxy-D-glucose Can Detect Recurrent Ovarian CarcinomaGynecologic Oncology, 1993
- Assessment of Primary and Metastatic Ovarian Cancer by Positron Emission Tomography (PET) Using 2-[18F]Deoxyglucose (2-[18F]FDG)Gynecologic Oncology, 1993
- Preoperative Staging of Uterine Cervical CarcinomaJournal of Computer Assisted Tomography, 1993
- CT and MR Accuracy in the Detection of Tumor Recurrence in Patients Treated for Ovarian CancerJournal of Computer Assisted Tomography, 1993